Literature DB >> 7153869

Urine flow-dependence of theophylline renal clearance in man.

D D Tang-Liu, T N Tozer, S Riegelman.   

Abstract

Theophylline renal clearance is highly dependent on urine flow rate and is neither concentration nor dose related. To examine the flow dependency, theophylline was administered in single doses (4.3 mg/kg to 8.6 mg/kg) to 14 volunteers. Seven of these volunteers participated in studies in which theophylline and metabolite concentrations were held constant at six different levels. Due to the diuretic effect of theophylline, its renal clearance contributed up to 70% of the time-averaged total clearance, dose/total area, in the first hour after a single dose. The contribution then dropped to 5% of the time-averaged total clearance when the normal urine flow rate was restored. As a consequence of extensive tubular reabsorption, the urine/plasma concentration ratio of theophylline varied with urine flow rate and approached the value of the unbound fraction in plasma. On assumption that the reabsorption is passive, a mathematical model was used to explain the urine flow dependence of reabsorption and, therefore, the renal clearance of theophylline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153869     DOI: 10.1007/bf01065168

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  26 in total

1.  Dose-dependent kinetics of theophylline disposition in asthmatic children.

Authors:  M Weinberger; E Ginchansky
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

3.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  Nonaldosterone influences on renal sodium transport.

Authors:  N G Levinsky
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

5.  Mathematical simulation of normal nephron function in rat and man.

Authors:  E Koushanpour; R R Tarica; W F Stevens
Journal:  J Theor Biol       Date:  1971-05       Impact factor: 2.691

6.  Measurement of excretion characteristics of theophylline and its major metabolites.

Authors:  J H Jonkman; D Tang; R A Upton; S Riegelman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.

Authors:  T J Monks; J Caldwell; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

8.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

9.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

10.  Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorption.

Authors:  A Arvidsson; O Borgå; G Alván
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

View more
  15 in total

1.  Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.

Authors:  Barent DuBois; Samantha Louey; George D Giraud; Ganesh Cherala; Sonnet S Jonker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-03-19       Impact factor: 4.080

Review 2.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Absence of a clinically significant interaction between theophylline and furosemide.

Authors:  U A Jänicke; B Krüdewagen; A Schulz; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

5.  Effect of zileuton on theophylline pharmacokinetics.

Authors:  G R Granneman; R A Braeckman; C S Locke; J H Cavanaugh; L M Dubé; W M Awni
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 6.  Effects of bladder resorption on pharmacokinetic data analysis.

Authors:  J T Dalton; M G Weintjes; J L Au
Journal:  J Pharmacokinet Biopharm       Date:  1994-06

7.  A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies.

Authors:  R A Upton; J F Thiercelin; J K Moore; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

8.  Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults.

Authors:  R A Upton; J F Thiercelin; T W Guentert; S M Wallace; J R Powell; L Sansom; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

9.  Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.

Authors:  I Bonnacker; D Berdel; R Süverkrüp; A von Berg
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 10.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.